144 related articles for article (PubMed ID: 35995727)
1. Corrigendum to "1,2-diacetylbenzene impaired hippocampal memory by activating proinflammatory cytokines and upregulating the prolactin pathway: An in vivo and in vitro study" [Int. Immunopharmacol. 108 (2022) 108901].
Nguyen HD; Jo WH; Hoang NHM; Yu BP; Chung HY; Kim MS
Int Immunopharmacol; 2022 Oct; 111():109156. PubMed ID: 35995727
[No Abstract] [Full Text] [Related]
2. 1,2-Diacetylbenzene impaired hippocampal memory by activating proinflammatory cytokines and upregulating the prolactin pathway: An in vivo and in vitro study.
Nguyen HD; Jo WH; Hoang NHM; Yu BP; Chung HY; Kim MS
Int Immunopharmacol; 2022 Jul; 108():108901. PubMed ID: 35729834
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "Isosteviol reduces acute inflammatory response after burn injurys by upregulating MMP9 in macrophages, leading to M2 polarization" [Int. Immunopharmacol. 106 (2022) 108609].
Qiao G; Ji W; Sun Z; Wang X; Li P; Jia H; Duan L; Qi F
Int Immunopharmacol; 2022 Dec; 113(Pt B):109414. PubMed ID: 36402673
[No Abstract] [Full Text] [Related]
4. Corrigendum to "Sivelestat ameliorates sepsis-induced myocardial dysfunction by activating the PI3K/AKT/mTOR signaling pathway" [Int. Immunopharmacol. 128 (2024) https://doi.org/10.1016/j.intimp.2023.111466].
Geng H; Zhang H; Cheng L; Dong S
Int Immunopharmacol; 2024 Apr; 131():111873. PubMed ID: 38514302
[No Abstract] [Full Text] [Related]
5. Corrigendum to "Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway" [Int. Immunopharmacol. 125(Part A) (2023) 111125].
Gao G; Xue Q; He J; Wu M; Jiang Y; Li Q; Zhang Y; Shi W
Int Immunopharmacol; 2024 Jan; 126():111292. PubMed ID: 38042635
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Paeonol derivative-6 attenuates inflammation by activating ZEB2 in acute liver injury" [Int. Immunopharmacol. 91 (2021) 107235].
Yang J; Xu L; Wu M; Fang H; Lu Y; Shi C; Wang Y; Li Z; Zhang L; Zhang L
Int Immunopharmacol; 2021 May; 94():107410. PubMed ID: 33578262
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Melatonin prevents endothelial dysfunction in SLE by activating the nuclear receptor retinoic acid-related orphan receptor-α" [Int. Immunopharmacol. 83 (2020) 106365].
Huang H; Liu X; Chen D; Lu Y; Li J; Du F; Zhang C; Lu L
Int Immunopharmacol; 2020 Sep; 86():106817. PubMed ID: 32736997
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis" [Int. Immunopharmacol. 90 (2021) 107187].
Wu YX; Zeng S; Wan BB; Wang YY; Sun HX; Liu G; Gao ZQ; Chen D; Chen YQ; Lu MD; Pang QF
Int Immunopharmacol; 2023 Nov; 124(Pt A):111008. PubMed ID: 37806791
[No Abstract] [Full Text] [Related]
9. Corrigendum to "Epigallocatechin gallate potentially abrogates fluoride induced lung oxidative stress, inflammation via Nrf2/Keap1 signaling pathway in rats: An in-vivo and in-silico study" [Int. Immunopharmacol. 39 (2016) 128-139].
Shanmugam T; Selvaraj M; Poomalai S
Int Immunopharmacol; 2020 Mar; 80():106203. PubMed ID: 31983588
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Tanshinone IIA analogue 15a inhibits NLRP3-mediated inflammation by activating mitophagy in macrophages to alleviate acute tubular necrosis" [Int. Immunopharmacol. 118 (2023) 110065].
Chen J; Luo W; Hu C; Ren M; Xu H; Xu X; Li W; Chen Y; Shao J; Xiao Z; Lv X; Liang G
Int Immunopharmacol; 2023 Aug; 121():110575. PubMed ID: 37407366
[No Abstract] [Full Text] [Related]
11. Corrigendum to 'In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects' [Int. Immunopharmacol. 87 (2020) 106787].
Ma W; Zhang Y; Yu M; Wang B; Xu S; Zhang J; Li X; Ye X
Int Immunopharmacol; 2020 Nov; 88():106899. PubMed ID: 32827917
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Canthaxanthin shows anti-liver aging and anti-liver fibrosis effects by down-regulating inflammation and oxidative stress in vivo and in vitro" [Int. Immunopharmacol. 110 (2022) 108942].
Li J; Xian L; Zheng R; Wang Y; Wan X; Liu Y
Int Immunopharmacol; 2022 Nov; 112():109189. PubMed ID: 36041256
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Baicalin suppresses IL-1β-induced expression of inflammatory cytokines via blocking NF-κB in human osteoarthritis chondrocytes and shows protective effect in mice osteoarthritis models" [Int. Immunopharmacol. 52 (2017) 218-226].
Chen C; Zhang C; Cai L; Xie H; Hu W; Wang T; Lu D; Chen H
Int Immunopharmacol; 2021 Jun; 95():107546. PubMed ID: 33735716
[No Abstract] [Full Text] [Related]
14. Corrigendum to "Emodin ameliorates ulcerative colitis by the flagellin-TLR5 dependent pathway in mice" [Int. Immunopharmacol. 59 (2018) 269-275].
Luo S; Deng X; Liu Q; Pan Z; Zhao Z; Zhou L; Luo X
Int Immunopharmacol; 2018 Sep; 62():337. PubMed ID: 29983242
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Protective effect of arctiin against Toxoplasma gondii HSP70-induced allergic acute liver injury by disrupting the TLR4-mediated activation of cytosolic phospholipase A2 and platelet-activating factor" [Int. Immunopharmacol. 126 (2023) 111254].
Lu JM; Xu X; Aosai F; Zhang MY; Zhou LL; Piao LX
Int Immunopharmacol; 2024 Jan; 127():111422. PubMed ID: 38143162
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].
Wen S; Wei Y; Zhang X; Bai F; Tan S; Nie J; Wei J; Lin X
Int Immunopharmacol; 2021 Mar; 92():107344. PubMed ID: 33418247
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Plasma levels of 12 different cytokines correlate to PD-1 inhibitor combined chemotherapy responses in advanced non-small-cell lung cancer patient" [Int. Immunopharmacol. 124(Part A) (2023) 110888].
Peng Y; Qi Q; Zhu M; Zhang Y; Bao Y; Liu Y
Int Immunopharmacol; 2023 Nov; 124(Pt A):110976. PubMed ID: 37778965
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Gallic acid improved inflammation via NF-κB pathway in TNBS-induced ulcerative colitis" [Int. Immunopharmacol. 67 (2019) 129-137].
Zhu L; Gu P; Shen H
Int Immunopharmacol; 2021 Oct; 99():107815. PubMed ID: 34130920
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK/HIF-1α pathway". [Int. Immunopharmacol. 87 (2020) 106830].
Yu Y; Cai W; Zhou J; Lu H; Wang Y; Song Y; He R; Pei F; Wang X; Zhang R; Liu H; Wei F
Int Immunopharmacol; 2021 Oct; 99():107911. PubMed ID: 34353734
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway" [Int. Immunopharmacol. 36 (2016) 132-141].
Yao H; Hu C; Yin L; Tao X; Xu L; Qi Y; Han X; Xu Y; Zhao Y; Wang C; Peng J
Int Immunopharmacol; 2019 Sep; 74():105786. PubMed ID: 31402320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
